AstraZeneca agrees $45m 'option' deal for asthma drug

16-07-2015

AstraZeneca has agreed a deal with drug maker Kyowa Hakko Kirin giving the UK pharmaceutical company the option to commercialise an asthma treatment in Japan.


AstraZeneca, Kyowa Hakko Kirin, research and development, benralizumab, licensing

LSIPR